OAM
PRNB

Oxford Asset Management’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Oxford Asset Management’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,072
Closed -$426K – 2236
2019
Q3 		$426K Buy
+15,072
New +$553K 0.01% 1326
2019
Q2 		– Sell
-17,501
Closed -$595K – 2064
2019
Q1 		$595K Sell
17,501
-49,426
-74% -$1.57M 0.01% 1141
2018
Q4 		$1.83M Sell
66,927
-44,416
-40% -$1.14M 0.05% 512
2018
Q3 		$3.23M Buy
+111,343
New +$3.14M 0.07% 402

Other funds holding PRNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Oxford Asset Management's PRNB Position: Q4 2019 in Review

Oxford Asset Management sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q4 2019, closing a stake of 15,072 shares — an estimated $426K sold.

Oxford Asset Management first reported a position in PRNB in Q3 2018 and held it in 4 quarters. The position peaked at $3.23M in Q3 2018. 115 funds tracked by Wall St. Rank hold PRNB as of Q4 2019.

  • Oxford Asset Management reported no remaining Principia Biopharma Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Oxford Asset Management sold 15,072 Principia Biopharma Inc. Common Stock shares in Q4 2019, an estimated $426K.
  • Oxford Asset Management first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 4 quarters.
  • Oxford Asset Management's Principia Biopharma Inc. Common Stock position peaked at $3.23M in Q3 2018.
  • 115 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q4 2019.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.